Pure Global

Effects of Diatermy in Patients With Fibromyalgia. - Trial NCT06414369

Access comprehensive clinical trial information for NCT06414369 through Pure Global AI's free database. This phase not specified trial is sponsored by Camilo Jose Cela University and is currently Not yet recruiting. The study focuses on Fibromyalgia. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06414369
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06414369
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effects of Diatermy in Patients With Fibromyalgia.

Study Focus

Fibromyalgia

Diathermy

Interventional

other

Sponsor & Location

Camilo Jose Cela University

Timeline & Enrollment

N/A

May 20, 2024

Jul 01, 2024

30 participants

Primary Outcome

Pain (VAS),Pain (algometry)

Summary

Diathermy is a non-invasive pain therapy based on the local application of high-frequency
 electromagnetic waves. This procedure produces deep heat promotes tissue repair and
 influences pain sensitivity. The main characteristic of fibromyalgia (FM) is generalized
 musculoskeletal pain. This may be accompanied by muscle and joint stiffness, sleep and mood
 disorders, anxiety and depression, cognitive dysfunction, and chronic fatigue. Endemic in
 developed countries, with a higher prevalence among women than men, and the etiology is still
 unknown. Diagnosis is made on chronic generalized pain and through the presence of tender
 points. The objective of this study will be to analyze the efficacy of diathermy on pain in
 patients with fibromyalgia

ICD-10 Classifications

Fibromyalgia
Myalgia
Fibrothorax
Cervicalgia
Epidemic myalgia

Data Source

ClinicalTrials.gov

NCT06414369

Non-Device Trial